首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >ONS-donor ligand based Pt(II) complexes display extremely high anticancer potency through autophagic cell death pathway
【24h】

ONS-donor ligand based Pt(II) complexes display extremely high anticancer potency through autophagic cell death pathway

机译:基于ONS-供体配体的PT(II)复合物通过自噬细胞死亡途径显示极高的抗癌效力

获取原文
获取原文并翻译 | 示例
           

摘要

The current study unveils ONS-donor ligand based Pt(II) complexes with unusual anticancer potency showing higher anticancer effect as compared to cisplatin. This series of Pt(lI)(R-salicylaldimine)Cl (C1a-C4a) (R = 5-H, 5-CH3, F, 3-CH3O) complexes were prepared in single step in good isolated yields from commercially available materials. The chloride ancillary ligand of "a" series (C1a-C4a) was replaced with 4-picoline and "b" series of four complexes Pt(II)(R-salicylaldimine)(4-picoline)BF4 (C1b-C4b) (R = 5-H, 5-CH3, F, 3-CH3O) was obtained. All these complexes were characterized by different structure elucidation techniques. Among these, the structures of C1a, C2a, C2b and Cab were determined in solid state by single crystal X-ray analysis. We found quick aquation of "a" series of complexes in DMSO/water mixture that was well investigated by H-1 NMNR, LCMS and ESI-MS, while "b" series of these complexes was quite stable over a month as described by the 1H NMNR in DMSO/D2O mixture. This ONS-donor ligand based class of Pt(11) complexes showed unusual anticancer potency in non-small cell lung cancer A549, colorectal cancer HT-29 and triple negative breast cancer MDA-MB-231 cells. These Pt(II) complexes induced PARP cleavage and significantly inhibited colony formation ability of cancer cells. Mechanistically, we found reduced aggressive growth of cancer cells by the induction of autophagic cell death via LC3-I/LC3-II expression and recruitment of LC3B to autophagosomal membrane. These complexes induced p21 expression, that suggested their potentials to suppress cell cycle progression. Significant activation of Caspase3/7-dependent apoptotic signaling was observed in cancer cells treated with these Pt(II) complexes. Morphological changes of cancer cells suggested their potentials to modulate epithelial-mesenchymal-transition (EMT) like features of cancer cells. Gel electrophoresis study revealed their interaction with plasmid DNA. Similarly, strong growth retardation effect and filamentous morphology was observed in Escherichia coli (E. coli). These ONS-donor Pt(II) complexes possessed strong anticancer effect in multiple human cancer cells via activation of multiple pathways for apoptotic and autophagic cell death. (C) 2018 Elsevier Masson SAS. All rights reserved.
机译:目前的研究揭示了基于供体的Pt(II)的Pt(II)配合物,其具有异常的抗癌效力,与顺铂相比显示出更高的抗癌效果。该系列的Pt(Li)(R-水杨酸亚胺)Cl(C1A-C4a)(R = 5-H,5-CH3,F,3-CH 3 O)复合物以商业上可获得的材料的良好分离的产率制备。将“A”系列(C1A-C4A)的氯化物辅助配体用4-吡啶和“B”系列的四个络合物Pt(II)(R-水杨酸二嗪)(4-吡啶)BF4(C1B-C4B)(R获得= 5-H,5-CH3,F,3-CH3O)。所有这些配合物都是通过不同的结构阐明技术的特征。其中,通过单晶X射线分析以固态确定C1A,C2A,C2B和驾驶室的结构。我们在DMSO /水混合物中发现了快速水中的“A”系列复合物,其通过H-1 NMNR,LCMS和ESI-MS进行良好研究,而“B”系列这些复合物在一个月内相当稳定,如此1H NMNR在DMSO / D2O混合物中。基于ONS-供体配体的PT(11)复合物类别在非小细胞肺癌A549,结肠直肠癌HT-29和三重阴性乳腺癌MDA-MB-231细胞中显示出异常的抗癌效力。这些PT(II)复合物诱导PARP切割并显着抑制癌细胞的菌落形成能力。机械地,我们发现通过LC3-I / LC3-II表达诱导自噬细胞死亡和LC3B对自噬体膜的募集来降低癌细胞的侵袭性生长。这些复合物诱导P21表达,表明它们抑制细胞周期进展的潜力。在用这些Pt(II)配合物处理的癌细胞中观察到Caspase3 / 7依赖性凋亡信号传导的显着激活。癌细胞的形态变化表明它们的潜力调节上皮 - 间充质转换(EMT),如癌细胞的特征。凝胶电泳研究表明它们与质粒DNA的相互作用。类似地,在大肠杆菌(大肠杆菌)中观察到强烈的生长延迟效应和丝状形态。这些ONS-供体PT(II)复合物通过对凋亡和自噬细胞死亡的多种途径激活多种途径具有强烈的抗癌效果。 (c)2018年Elsevier Masson SAS。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号